Well Done LLC Sells 315 Shares of Colgate-Palmolive (NYSE:CL)

Well Done LLC lowered its stake in Colgate-Palmolive (NYSE:CL) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,231 shares of the company’s stock after selling 315 shares during the period. Well Done LLC’s holdings in Colgate-Palmolive were worth $2,250,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. OFI Invest Asset Management purchased a new position in Colgate-Palmolive in the third quarter worth $25,000. Quarry LP lifted its holdings in shares of Colgate-Palmolive by 48.2% in the 2nd quarter. Quarry LP now owns 446 shares of the company’s stock worth $34,000 after acquiring an additional 145 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its stake in shares of Colgate-Palmolive by 142.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares during the period. West Tower Group LLC purchased a new position in shares of Colgate-Palmolive during the second quarter valued at approximately $36,000. Finally, McCarthy Grittinger Financial Group LLC purchased a new position in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $37,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL traded up $0.45 during trading on Wednesday, reaching $89.35. 2,233,961 shares of the stock were exchanged, compared to its average volume of 4,683,919. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $90.27. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The stock has a 50-day moving average price of $85.17 and a 200-day moving average price of $78.87. The firm has a market cap of $73.55 billion, a PE ratio of 31.98, a PEG ratio of 3.37 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The business had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. During the same quarter last year, the firm earned $0.77 earnings per share. Colgate-Palmolive’s quarterly revenue was up 6.9% on a year-over-year basis. Research analysts expect that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.24%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 69.06%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on CL shares. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price on the stock in a research report on Monday, January 29th. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Barclays increased their price objective on Colgate-Palmolive from $75.00 to $82.00 and gave the company an “equal weight” rating in a report on Tuesday, January 16th. The Goldman Sachs Group began coverage on Colgate-Palmolive in a research note on Friday, March 1st. They set a “buy” rating and a $93.00 price target on the stock. Finally, Bank of America upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 price target on the stock in a research report on Friday, December 15th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $87.31.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Jennifer Daniels sold 61,633 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the sale, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the transaction, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 232,371 shares of company stock worth $19,505,099. 0.34% of the stock is currently owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.